Published in Biotech Business Week, January 21st, 2008
"This exciting Mayo Clinic work supported the initiation of our combination REOLYSIN® and cyclophosphamide clinical trial, recently...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.